Ophthalmology PACS (Picture Archiving and Communication System) Market by Type (Standalone, Integrated), Delivery (On-premise, Cloud), End User (Hospitals, Specialty Clinic, ASC), Region (North America (US, Canada) Europe, Asia) - Global Forecast to 2023
“The global ophthalmology PACS market is projected to grow at 8.5% during the forecast period.”
The global ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.
“By delivery model, web/cloud-based models are expected to grow at the highest CAGR during the forecast period.”
On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. Cloud-based models do not incur any major setup charges. Additionally, the maintenance and support service charges are also inclusive of the subscription fees, making these delivery modes more affordable for customers.
“Asia to witness high growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this regional segment is attributed to the increasing demand for diagnostic imaging procedures, growing medical tourism, increasing geriatric population and incidence of age-related eye diseases, growing awareness on healthcare services, rising healthcare expenditure, and developing healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
The report provides an overview of the ophthalmology PACS market. It aims at estimating the market size and growth potential of this market across different segments such as type, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the ophthalmology PACS market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
The global ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. Growth in this market is mainly driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology. On the other hand, high implementation and maintenance costs are expected to limit market growth during the forecast period. Poor compatibility with informatics standards may also challenge market growth to a certain extent.
“By delivery model, web/cloud-based models are expected to grow at the highest CAGR during the forecast period.”
On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. The web/cloud-based PACS segment is expected to grow at the highest CAGR during the forecast period. Cloud-based models do not incur any major setup charges. Additionally, the maintenance and support service charges are also inclusive of the subscription fees, making these delivery modes more affordable for customers.
“Asia to witness high growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period. The high growth of this regional segment is attributed to the increasing demand for diagnostic imaging procedures, growing medical tourism, increasing geriatric population and incidence of age-related eye diseases, growing awareness on healthcare services, rising healthcare expenditure, and developing healthcare infrastructure.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 30%; Tier 2 - 42%; Tier 3 - 28%.
- By Designation: C-level- 25%; D-level- 45%; others-30%.
- By Region: North America-34%; Europe-28%; Asia -32%; RoW-6%.
- Carl Zeiss Meditec AG (Germany)
- Topcon Corporation (Japan)
- Heidelberg Engineering (Germany)
- Sonomed Escalon (US)
- Visbion (UK)
- EyePACS (US)
- IBM Corporation (Merge Healthcare) (US)
- VersaSuite (US)
- Medical Standard (South Korea)
- ScImage (US)
The report provides an overview of the ophthalmology PACS market. It aims at estimating the market size and growth potential of this market across different segments such as type, delivery model, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the ophthalmology PACS market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.3.2 MARKETS COVERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OPHTHALMOLOGY PACS: MARKET OVERVIEW
4.2 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2018–2023
4.3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2018 VS. 2023 (USD MILLION)
4.4 OPHTHALMOLOGY PACS MARKET, BY END USER (2018)
4.5 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rapid growth in the geriatric population
5.2.1.2 Rising prevalence of eye diseases
5.2.1.3 Limited number of ophthalmologists
5.2.1.4 Government initiatives to encourage adoption of EHR/EMR
5.2.1.5 Expansion of teleophthalmology
5.2.2 RESTRAINTS
5.2.2.1 High implementation and maintenance costs
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Integration with EHR/EMR
5.2.3.3 High-growth opportunities represented by cloud-based platforms
5.2.4 CHALLENGES
5.2.4.1 Poor compatibility with informatics standards
6 INDUSTRY INSIGHTS
6.1 NEW VS. REPLACEMENT MARKET
6.2 PACS VS. VENDOR NEUTRAL PACS
6.3 OPHTHALMOLOGISTS VS. OPTOMETRISTS
6.4 MARKET ENTRY STRATEGY
6.4.1 KEY FUNCTIONALITIES REQUIRED:
6.5 LIST OF OPHTHALMOLOGY/OPTOMETRY PRACTICES, BY REGION
7 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL
7.1 INTRODUCTION
7.2 ON-PREMISE MODEL
7.3 WEB/CLOUD-BASED MODELS
8 OPHTHALMOLOGY PACS MARKET, BY TYPE
8.1 INTRODUCTION
8.2 INTEGRATED PACS
8.3 STANDALONE PACS
9 OPHTHALMOLOGY PACS MARKET, BY END USER
9.1 INTRODUCTION
9.2 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS (ASCS)
9.3 HOSPITALS
9.4 OTHER END USERS
10 OPHTHALMOLOGY PACS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ROE
10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SINGAPORE
10.4.5 REST OF ASIA (ROA)
10.5 PACIFIC COUNTRIES
10.6 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 EXPANSIONS (2015–2018)
11.3.2 MERGERS AND ACQUISITIONS (2015–2018)
11.3.3 PRODUCT LAUNCHES AND ENHANCEMENTS (2015–2018)
11.3.4 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2015–2018)
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IBM CORPORATION (MERGE HEALTHCARE INCORPORATED)
12.2 CARL ZEISS MEDITEC AG
12.3 TOPCON CORPORATION
12.4 HEIDELBERG ENGINEERING
12.5 SONOMED ESCALON
12.6 VISBION
12.7 EYEPACS
12.8 VERSASUITE
12.9 MEDICAL STANDARD
12.10 SCIMAGE
12.11 AGFA-GEVAERT GROUP
12.12 CANON USA, INC.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.3.2 MARKETS COVERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 OPHTHALMOLOGY PACS: MARKET OVERVIEW
4.2 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2018–2023
4.3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2018 VS. 2023 (USD MILLION)
4.4 OPHTHALMOLOGY PACS MARKET, BY END USER (2018)
4.5 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rapid growth in the geriatric population
5.2.1.2 Rising prevalence of eye diseases
5.2.1.3 Limited number of ophthalmologists
5.2.1.4 Government initiatives to encourage adoption of EHR/EMR
5.2.1.5 Expansion of teleophthalmology
5.2.2 RESTRAINTS
5.2.2.1 High implementation and maintenance costs
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Integration with EHR/EMR
5.2.3.3 High-growth opportunities represented by cloud-based platforms
5.2.4 CHALLENGES
5.2.4.1 Poor compatibility with informatics standards
6 INDUSTRY INSIGHTS
6.1 NEW VS. REPLACEMENT MARKET
6.2 PACS VS. VENDOR NEUTRAL PACS
6.3 OPHTHALMOLOGISTS VS. OPTOMETRISTS
6.4 MARKET ENTRY STRATEGY
6.4.1 KEY FUNCTIONALITIES REQUIRED:
6.5 LIST OF OPHTHALMOLOGY/OPTOMETRY PRACTICES, BY REGION
7 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL
7.1 INTRODUCTION
7.2 ON-PREMISE MODEL
7.3 WEB/CLOUD-BASED MODELS
8 OPHTHALMOLOGY PACS MARKET, BY TYPE
8.1 INTRODUCTION
8.2 INTEGRATED PACS
8.3 STANDALONE PACS
9 OPHTHALMOLOGY PACS MARKET, BY END USER
9.1 INTRODUCTION
9.2 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS (ASCS)
9.3 HOSPITALS
9.4 OTHER END USERS
10 OPHTHALMOLOGY PACS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ROE
10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 SINGAPORE
10.4.5 REST OF ASIA (ROA)
10.5 PACIFIC COUNTRIES
10.6 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SCENARIO
11.3.1 EXPANSIONS (2015–2018)
11.3.2 MERGERS AND ACQUISITIONS (2015–2018)
11.3.3 PRODUCT LAUNCHES AND ENHANCEMENTS (2015–2018)
11.3.4 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2015–2018)
12 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 IBM CORPORATION (MERGE HEALTHCARE INCORPORATED)
12.2 CARL ZEISS MEDITEC AG
12.3 TOPCON CORPORATION
12.4 HEIDELBERG ENGINEERING
12.5 SONOMED ESCALON
12.6 VISBION
12.7 EYEPACS
12.8 VERSASUITE
12.9 MEDICAL STANDARD
12.10 SCIMAGE
12.11 AGFA-GEVAERT GROUP
12.12 CANON USA, INC.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 PROJECTED INCREASE IN GERIATRIC POPULATION, 2000 TO 2050
TABLE 2 PREVALENCE OF LEADING EYE DISEASES AMONG ADULTS
ABOVE 40 YEARS OF AGE) IN THE US
TABLE 3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 4 ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 5 NORTH AMERICA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 6 EUROPE: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 7 ASIA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 8 WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 9 NORTH AMERICA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, 2016–2023 (USD MILLION)
TABLE 10 EUROPE: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 11 ASIA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 12 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 13 INTEGRATED OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 14 NORTH AMERICA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 15 EUROPE: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 16 ASIA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 17 STANDALONE OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 18 NORTH AMERICA: STANDALONE OPHTHALMOLOGY PACS MARKET, 2016–2023 (USD MILLION)
TABLE 19 EUROPE: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 20 ASIA: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 21 OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 22 OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 23 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 24 EUROPE: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 25 ASIA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 26 OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION)
TABLE 27 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 28 EUROPE: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 29 ASIA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30 OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 31 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 32 EUROPE: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 33 ASIA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 34 OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 35 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 36 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 37 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 38 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 39 INCREASE IN DISEASE PREVALENCE, 2013 VS 2030 (MILLION PATIENTS)
TABLE 40 US: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 41 US: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 42 US: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 43 CANADA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 44 CANADA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 45 CANADA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 46 EUROPE: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 47 EUROPE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 48 EUROPE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 49 EUROPE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 50 GERMANY: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 51 GERMANY: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 52 GERMANY: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 53 FRANCE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 54 FRANCE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 55 FRANCE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 56 UK: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 57 UK: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 58 UK: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 59 ROE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 60 ROE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 61 ROE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 62 ASIA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 63 ASIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 64 ASIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 65 ASIA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 66 JAPAN: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 67 JAPAN: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 68 JAPAN: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 69 CHINA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 70 CHINA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 71 CHINA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 72 INDIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 73 INDIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 74 INDIA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 75 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 76 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 77 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 78 ROA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 79 ROA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 80 ROA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 81 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 82 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 83 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 84 ROW: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 85 ROW: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 86 ROW: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 1 PROJECTED INCREASE IN GERIATRIC POPULATION, 2000 TO 2050
TABLE 2 PREVALENCE OF LEADING EYE DISEASES AMONG ADULTS
ABOVE 40 YEARS OF AGE) IN THE US
TABLE 3 OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 4 ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 5 NORTH AMERICA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 6 EUROPE: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 7 ASIA: ON-PREMISE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 8 WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 9 NORTH AMERICA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, 2016–2023 (USD MILLION)
TABLE 10 EUROPE: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 11 ASIA: WEB/CLOUD-BASED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 12 OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 13 INTEGRATED OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 14 NORTH AMERICA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 15 EUROPE: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 16 ASIA: INTEGRATED OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 17 STANDALONE OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 18 NORTH AMERICA: STANDALONE OPHTHALMOLOGY PACS MARKET, 2016–2023 (USD MILLION)
TABLE 19 EUROPE: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 20 ASIA: STANDALONE OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 21 OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 22 OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 23 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 24 EUROPE: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 25 ASIA: OPHTHALMOLOGY PACS MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 26 OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY REGION, 2016–2023 (USD MILLION)
TABLE 27 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 28 EUROPE: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 29 ASIA: OPHTHALMOLOGY PACS MARKET FOR HOSPITALS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 30 OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
TABLE 31 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 32 EUROPE: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 33 ASIA: OPHTHALMOLOGY PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 34 OPHTHALMOLOGY PACS MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 35 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 36 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 37 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 38 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 39 INCREASE IN DISEASE PREVALENCE, 2013 VS 2030 (MILLION PATIENTS)
TABLE 40 US: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 41 US: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 42 US: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 43 CANADA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 44 CANADA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 45 CANADA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 46 EUROPE: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 47 EUROPE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 48 EUROPE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 49 EUROPE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 50 GERMANY: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 51 GERMANY: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 52 GERMANY: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 53 FRANCE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 54 FRANCE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 55 FRANCE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 56 UK: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 57 UK: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 58 UK: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 59 ROE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 60 ROE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 61 ROE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 62 ASIA: OPHTHALMOLOGY PACS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
TABLE 63 ASIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 64 ASIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 65 ASIA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 66 JAPAN: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 67 JAPAN: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 68 JAPAN: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 69 CHINA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 70 CHINA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 71 CHINA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 72 INDIA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 73 INDIA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 74 INDIA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 75 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 76 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 77 SINGAPORE: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 78 ROA: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 79 ROA: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 80 ROA: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 81 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 82 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 83 PACIFIC COUNTRIES: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
TABLE 84 ROW: OPHTHALMOLOGY PACS MARKET, BY TYPE, 2016–2023 (USD MILLION)
TABLE 85 ROW: OPHTHALMOLOGY PACS MARKET, BY DELIVERY MODEL, 2016–2023 (USD MILLION)
TABLE 86 ROW: OPHTHALMOLOGY PACS MARKET, BY END USER, 2016–2023 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 5 INTEGRATED PACS TO DOMINATE THE OPHTHALMOLOGY PACS MARKET DURING THE FORECAST PERIOD
FIGURE 6 ON-PREMISE MODELS TO ACCOUNT FOR THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 7 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET
FIGURE 9 RAPID GROWTH IN THE GERIATRIC POPULATION AND RISING PREVALENCE OF EYE DISEASES—KEY DRIVERS FOR MARKET GROWTH
FIGURE 10 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH RATE IN THE OPHTHALMOLOGY PACS MARKET BETWEEN 2018 AND 2023
FIGURE 11 WEB/CLOUD-BASED MODELS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
FIGURE 12 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS SEGMENT TO HOLD THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 13 MARKET IN ASIA PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023)
FIGURE 14 OPHTHALMOLOGY PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 OPHTHALMOLOGY PACS: NEW VS. REPLACEMENT MARKET FOR OPHTHALMOLOGISTS AND OPTOMETRISTS - 2017
FIGURE 16 PACS VS VENDOR NEUTRAL PACS - 2018 VS 2023
FIGURE 17 OPHTHALMOLOGISTS VS. OPTOMETRISTS - 2017
FIGURE 18 WEB/CLOUD-BASED MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 19 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 20 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 21 NORTH AMERICA TO DOMINATE THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 22 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 23 EUROPE: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 24 ASIA: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS IN THE OPHTHALMOLOGY PACS MARKET BETWEEN 2015 AND 2018
FIGURE 26 MARKET EVOLUTION FRAMEWORK
FIGURE 27 OPHTHALMOLOGY PACS MARKET SHARE ANALYSIS, 2017
FIGURE 28 IBM: COMPANY SNAPSHOT (2017)
FIGURE 29 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2017)
FIGURE 30 TOPCON CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 31 SONOMED ESCALON: COMPANY SNAPSHOT (2017)
FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2017)
FIGURE 33 CANON INC.: COMPANY SNAPSHOT (2017)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 5 INTEGRATED PACS TO DOMINATE THE OPHTHALMOLOGY PACS MARKET DURING THE FORECAST PERIOD
FIGURE 6 ON-PREMISE MODELS TO ACCOUNT FOR THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 7 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OPHTHALMOLOGY PACS MARKET
FIGURE 9 RAPID GROWTH IN THE GERIATRIC POPULATION AND RISING PREVALENCE OF EYE DISEASES—KEY DRIVERS FOR MARKET GROWTH
FIGURE 10 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH RATE IN THE OPHTHALMOLOGY PACS MARKET BETWEEN 2018 AND 2023
FIGURE 11 WEB/CLOUD-BASED MODELS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
FIGURE 12 SPECIALTY CLINICS & AMBULATORY SURGICAL CENTERS SEGMENT TO HOLD THE LARGEST SHARE OF THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 13 MARKET IN ASIA PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018–2023)
FIGURE 14 OPHTHALMOLOGY PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 OPHTHALMOLOGY PACS: NEW VS. REPLACEMENT MARKET FOR OPHTHALMOLOGISTS AND OPTOMETRISTS - 2017
FIGURE 16 PACS VS VENDOR NEUTRAL PACS - 2018 VS 2023
FIGURE 17 OPHTHALMOLOGISTS VS. OPTOMETRISTS - 2017
FIGURE 18 WEB/CLOUD-BASED MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 19 INTEGRATED PACS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 20 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 21 NORTH AMERICA TO DOMINATE THE OPHTHALMOLOGY PACS MARKET IN 2018
FIGURE 22 NORTH AMERICA: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 23 EUROPE: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 24 ASIA: OPHTHALMOLOGY PACS MARKET SNAPSHOT
FIGURE 25 KEY DEVELOPMENTS IN THE OPHTHALMOLOGY PACS MARKET BETWEEN 2015 AND 2018
FIGURE 26 MARKET EVOLUTION FRAMEWORK
FIGURE 27 OPHTHALMOLOGY PACS MARKET SHARE ANALYSIS, 2017
FIGURE 28 IBM: COMPANY SNAPSHOT (2017)
FIGURE 29 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2017)
FIGURE 30 TOPCON CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 31 SONOMED ESCALON: COMPANY SNAPSHOT (2017)
FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2017)
FIGURE 33 CANON INC.: COMPANY SNAPSHOT (2017)
